VU 0364849

Suppliers

Names

[ CAS No. ]:
1206711-14-9

[ Name ]:
VU 0364849

[Synonym ]:
DMH2
4-(6-{4-[2-(4-Morpholinyl)ethoxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)quinoline
VU0364849
4-[6-[4-[2-(4-Morpholinyl)ethoxy]phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline
Quinoline, 4-[6-[4-[2-(4-morpholinyl)ethoxy]phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Molecular Formula ]:
C27H25N5O2

[ Molecular Weight ]:
451.520

[ Exact Mass ]:
451.200836

[ LogP ]:
2.09

[ Index of Refraction ]:
1.689

Safety Information

[ RIDADR ]:
NONH for all modes of transport

Articles

Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin.

Mol. Cancer 12(1) , 129, (2013)

Bone morphogenetic proteins (BMP) are embryonic morphogens that are aberrantly expressed in lung cancer. BMPs mediate cell fate decisions and self-renewal of stem cells, through transcription regulati...


More Articles


Related Compounds

  • VU 0360223
  • VU 590 dihydrochloride
  • VU 0038882
  • VU 0155041
  • VU 0365114
  • VU 1545
  • 1,1-Dimethylethyl (2R,3R)-3-hydroxy-5-oxo-2-(phenylmethyl)-1-pyrrolidinecarboxylate
  • N-(1,3-benzodioxol-5-yl)-7H-purin-6-amine
  • N-(1-benzyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-2,5-dimethylbenzenesulfonamide
  • 1-(Dimethoxymethyl)-3-(trifluoromethyl)benzene
  • N-(1-benzyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-4-ethoxy-3-fluorobenzenesulfonamide
  • Ethyl 2-(thiophen-2-yl)ethylcarbamate
  • N-(1-butyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)propane-1-sulfonamide
  • N-(1-butyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-2,5-dimethylbenzenesulfonamide
  • 3,4-dicyano-N-methylbenzene-1-sulfonamide
  • N-(1-butyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-4-fluoro-2-methylbenzenesulfonamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.